查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1934181

皮膚化妝品市場－全球產業規模、佔有率、趨勢、機會和預測：產品類型、治療類型、最終用戶、分銷管道、地區和競爭格局，2021-2031年

Dermocosmetics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Skincare, Haircare ), By Treatment Type (Skin, Hair ), By End-User, By Distribution Channel, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球皮膚化妝品市場預計將從 2025 年的 566.9 億美元成長到 2031 年的 912.2 億美元，複合年成長率達到 8.25%。

皮膚護理產品位於化妝品和藥品的交叉領域，是專門針對特定皮膚問題（例如衰老、色素沉著和痤瘡）而設計的配方，旨在促進皮膚健康。市場成長的主要促進因素包括全球皮膚疾病發病率的上升、人口老化導致人們傾向於選擇非侵入性美容方式，以及消費者對經臨床科學驗證的成分的需求不斷成長。此外，數位平台的普及化進一步放大了這些因素，提高了專業級產品的可近性，並使消費者能夠在傳統醫療機構之外獲得針對性的治療。

市場概覽
預測期 2027-2031
市場規模：2025年 566.9億美元
市場規模：2031年 912.2億美元
複合年成長率：2026-2031年 8.25%
成長最快的細分市場 線上
最大的市場 歐洲

然而，由於各地區法規環境複雜且分散，該行業面臨許多挑戰，導致產品核准延遲，並增加了製造商的合規成本。仿冒品的存在往往會加劇這種監管負擔，並損害品牌聲譽。為了凸顯該行業的重要性，《歐洲化妝品》雜誌報告稱，預計到2024年，歐洲個人護理和化妝品市場規模將達到1039億歐元，其中護膚品（包括皮膚護理產品）將佔據最大佔有率，達28.9%。這些數據表明，皮膚健康解決方案對整個個人護理市場做出了顯著的經濟貢獻。

市場促進因素

皮膚疾病和皮膚問題的日益增加是推動市場擴張的主要動力，從根本上改變了消費者的護膚重點。隨著都市化、環境壓力和生活方式改變等因素導致皮膚疾病發病率上升，消費者正積極尋求能夠帶來實際醫療改善的治療方案，而不僅僅是追求美容效果。例如，《皮膚病學時報》2025年6月刊發表了報導，指出美國2021年新增痤瘡病例超過440萬例，比2010年成長了14.3%。診斷病例的激增正在推動行業結構性變革，並增加了對能夠有效治療特定皮膚疾病的專業皮膚護理配方的需求。

同時，意識提升，也推動了市場的發展。現今的消費者越來越了解胜肽、神經醯胺和類視色素等成分，並且傾向於選擇經過科學驗證的、功效卓著的產品，而非普通的美容產品。這種對功效的偏好也體現在企業的財務數據中。例如，高德美公司在2025年3月發布的報告顯示，其皮膚科護膚部門的淨銷售額將達到13.31億美元，年增10.7%，這主要得益於其高階科學產品系列。這一趨勢展現了該產業的強勁經濟實力。歐萊雅金融發布的2025年報告預測，其2024年皮膚科美容部門的銷售額將超過70億歐元，進一步印證了全球對高效皮膚健康解決方案的持續需求。

市場挑戰

全球範圍內複雜且分散的法規結構對皮膚化妝品市場的成長構成了重大障礙。製造商必須應對大量相互衝突的合規標準，這往往迫使他們花費巨資重新設計產品並進行重複測試，以滿足當地法規的要求。這種缺乏協調性的做法增加了營運成本，延長了新產品的上市時間，從而降低了企業應對新興消費趨勢的靈活性。因此，原本可以用於創新的資源被轉移到了政府合規方面，對營運效率造成了沉重的負擔。

這種充滿挑戰的法規環境尤其影響品牌擴充性，因為產品出口障礙限制了潛在收入。儘管該行業高度依賴國際貿易，但監管方面的不一致仍然威脅著這項貿易。根據歐洲化妝品協會（Cosmetics Europe）預測，到2024年，歐洲化妝品產業的全球出口額預計將超過290億歐元。雖然這個數字凸顯了跨境貿易的重要性，但不同監管體系造成的摩擦阻礙了出口能力的充分利用，最終減緩了整體經濟成長。

市場趨勢

生物技術在永續活性成分領域的應用日益廣泛，正在改變全球皮膚化妝品市場。製造商正從傳統的萃取方法轉向純度更高、環境影響更小的替代種植方法。這種轉變促進了高效配方（包括生物發酵活性成分）的研發，滿足了消費者對永續性和經皮膚科驗證的功效的需求，同時又不消耗自然資源。支撐這項轉變的經濟動力在供應鏈中也顯而易見。根據奇華頓公司於2025年1月發布的“2024會計年度全年業績報告”，其活性美容部門實現了11.1%的同比成長，表明市場對這些高性能生物基成分的需求不斷成長。

同時，人工智慧驅動的皮膚診斷和個人化技術的快速融合，正從根本上改變消費者發現和選擇護膚方案的方式，將專業皮膚科與居家護理相結合。借助以數據為中心的演算法，品牌可以直接向用戶提供先進的皮膚分析和客製化的產品提案，而這需要對數位生態系統進行大量投資。為了體現這一策略重點，拜爾斯道夫在2025年2月發布的2024年度報告中揭露，該公司已將其在數位媒體上的廣告支出提高至總廣告支出的70%。這凸顯了精準的數位平台在提供個人化護膚解決方案方面的重要性。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球肌膚化妝品市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品種類（護膚（乳霜、乳液、洗面乳等）、護髮品（洗髮精、護髮素、精油等））
    • 治療類型（皮膚（抗衰老、痤瘡治療、其他）、頭髮（去屑、防脫髮、頭髮再生、其他））
    • 依最終使用者（診所、水療中心和美容院、醫院、家庭）分類
    • 按分銷管道（藥局/藥局、線上、非零售通路）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美皮膚化妝品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲皮膚化妝品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章 亞太地區皮膚化妝品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲皮膚化妝品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲皮膚化妝品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球皮膚化妝品市場展望

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • The Procter & Gamble Company
  • L'Oreal SA
  • Unilever PLC
  • Johnson & Johnson Services, Inc.
  • The Avon Company
  • Bausch Health Companies Inc.
  • Galderma SA
  • Kanebo Cosmetics Inc.
  • Beiersdorf AG
  • AMOREPACIFIC US, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 14979

The Global Dermocosmetics Market is projected to expand from USD 56.69 Billion in 2025 to USD 91.22 Billion by 2031, achieving a CAGR of 8.25%. Situated at the convergence of cosmetics and pharmaceuticals, dermocosmetics are specialized formulations engineered to enhance skin health by treating specific dermatological issues such as aging, hyperpigmentation, and acne. The market's growth is largely fueled by the increasing global incidence of skin conditions, an aging demographic favoring non-invasive aesthetic options, and a rising consumer demand for ingredients backed by clinical science. These drivers are further amplified by the proliferation of digital platforms, which have improved the accessibility of professional-grade products, allowing consumers to secure targeted treatments outside of conventional medical environments.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 56.69 Billion
Market Size 2031USD 91.22 Billion
CAGR 2026-20318.25%
Fastest Growing SegmentOnline
Largest MarketEurope

However, the industry faces substantial hurdles due to a complicated and disjointed regulatory environment across various regions, which can retard product approvals and elevate compliance costs for manufacturers. This regulatory strain is frequently exacerbated by the presence of counterfeit products that threaten brand reputation. Highlighting the economic significance of the sector, Cosmetics Europe reported that the European personal care and cosmetics market was valued at 103.9 billion euros in 2024, with the skin care segment-which includes dermocosmetics-commanding the largest share at 28.9%. This data emphasizes the vital economic contribution of skin health solutions within the broader personal care landscape.

Market Driver

The escalating prevalence of dermatological disorders and skin conditions serves as a primary engine for market expansion, fundamentally shifting consumer skincare priorities. As factors such as urbanization, environmental stressors, and lifestyle changes increase the incidence of skin ailments, consumers are actively searching for therapeutic solutions that provide tangible medical improvements rather than just aesthetic enhancements. Highlighting this growing issue, a June 2025 article in Dermatology Times titled 'The Growing Burden of Acne in America' noted that the US recorded over 4.4 million new cases of acne in 2021, marking a 14.3% rise since 2010. This surge in diagnoses is driving a structural transformation in the industry, necessitating specialized dermocosmetic formulations capable of effectively managing specific pathologies.

Simultaneously, the market is driven by heightened consumer awareness regarding active ingredients and clinical efficacy. Modern shoppers are increasingly knowledgeable about components like peptides, ceramides, and retinoids, favoring science-backed products with verified results over generic beauty items. This preference for validated performance is reflected in corporate financials; for instance, Galderma's 'Full Year 2024 Results' from March 2025 reported that its Dermatological Skincare net sales hit 1.331 billion USD, achieving 10.7% growth due to its premium scientific portfolio. This trend demonstrates the sector's economic strength, further evidenced by L'Oreal Finance, which reported in 2025 that its Dermatological Beauty Division generated sales exceeding 7 billion euros in 2024, confirming the sustained global demand for effective skin health solutions.

Market Challenge

The complicated and fragmented regulatory framework across various global regions acts as a major impediment to the growth of the dermocosmetics market. Manufacturers must navigate a conflicting array of compliance standards, a reality that often forces expensive product reformulations and redundant testing to satisfy local requirements. This lack of harmonization increases operational costs and prolongs the time-to-market for new products, thereby diminishing the agility of companies to respond to emerging consumer trends. Consequently, resources that could otherwise be invested in innovation are diverted toward administrative compliance, creating a significant burden on operational efficiency.

This difficult regulatory environment particularly impacts the international scalability of brands, as barriers to seamless product exportation restrict potential revenue. While the sector relies heavily on global trade, regulatory discrepancies continually threaten this exchange. According to Cosmetics Europe, the European cosmetics industry recorded global exports surpassing 29 billion euros in 2024. Although this figure underscores the critical nature of cross-border commerce, the friction generated by divergent regulatory systems prevents the market from fully exploiting this export capacity, ultimately slowing broader economic expansion.

Market Trends

The growing application of biotechnology for sustainable active ingredients is transforming the global dermocosmetics market, as manufacturers move from traditional extraction methods to lab-grown alternatives that ensure higher purity and reduced environmental impact. This shift facilitates the development of potent formulations, such as bio-fermented actives, which address the dual consumer desire for sustainability and proven dermatological efficacy without depleting natural resources. The economic momentum behind this transition is evident in the supply chain; according to Givaudan's '2024 Full year results' published in January 2025, the company's Active Beauty division achieved a like-for-like growth of 11.1%, signaling surging industrial demand for these high-performance, bio-based components.

Concurrently, the rapid integration of AI-driven skin diagnostics and personalization is fundamentally altering how consumers discover and select skincare routines by connecting professional dermatology with home care. By utilizing data-centric algorithms, brands can provide sophisticated skin analysis and customized product recommendations directly to users, a capability that necessitates significant investment in digital ecosystems. Reflecting this strategic focus, Beiersdorf's 'Annual Report 2024', released in February 2025, revealed that the company increased its digital working media spend to 70% of its total working media expenditure, highlighting the essential role of targeted digital platforms in delivering personalized skincare solutions.

Key Market Players

  • The Procter & Gamble Company
  • L'Oreal S.A
  • Unilever PLC
  • Johnson & Johnson Services, Inc.
  • The Avon Company
  • Bausch Health Companies Inc.
  • Galderma SA
  • Kanebo Cosmetics Inc.
  • Beiersdorf AG
  • AMOREPACIFIC US, Inc.

Report Scope

In this report, the Global Dermocosmetics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dermocosmetics Market, By Product Type

  • Skincare (Cream, Lotion, Cleanser, Others)
  • Haircare (Shampoo, Conditioner, Oil, Others)

Dermocosmetics Market, By Treatment Type

  • Skin (Anti-Aging, Acne-Treatment, Others)
  • Hair (Anti-Dandruff, Anti-Hair Fall, Hair Repair, Others)

Dermocosmetics Market, By End-User

  • Clinics
  • Spas & Salons
  • Hospitals
  • At Home

Dermocosmetics Market, By Distribution Channel

  • Pharmacy & Drug Stores
  • Online
  • Non-Retail

Dermocosmetics Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dermocosmetics Market.

Available Customizations:

Global Dermocosmetics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Dermocosmetics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Skincare (Cream, Lotion, Cleanser, Others), Haircare (Shampoo, Conditioner, Oil, Others))
    • 5.2.2. By Treatment Type (Skin (Anti-Aging, Acne-Treatment, Others), Hair (Anti-Dandruff, Anti-Hair Fall, Hair Repair, Others))
    • 5.2.3. By End-User (Clinics, Spas & Salons, Hospitals, At Home)
    • 5.2.4. By Distribution Channel (Pharmacy & Drug Stores, Online, Non-Retail)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Dermocosmetics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Treatment Type
    • 6.2.3. By End-User
    • 6.2.4. By Distribution Channel
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Dermocosmetics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Treatment Type
        • 6.3.1.2.3. By End-User
        • 6.3.1.2.4. By Distribution Channel
    • 6.3.2. Canada Dermocosmetics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Treatment Type
        • 6.3.2.2.3. By End-User
        • 6.3.2.2.4. By Distribution Channel
    • 6.3.3. Mexico Dermocosmetics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Treatment Type
        • 6.3.3.2.3. By End-User
        • 6.3.3.2.4. By Distribution Channel

7. Europe Dermocosmetics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Treatment Type
    • 7.2.3. By End-User
    • 7.2.4. By Distribution Channel
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Dermocosmetics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Treatment Type
        • 7.3.1.2.3. By End-User
        • 7.3.1.2.4. By Distribution Channel
    • 7.3.2. France Dermocosmetics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Treatment Type
        • 7.3.2.2.3. By End-User
        • 7.3.2.2.4. By Distribution Channel
    • 7.3.3. United Kingdom Dermocosmetics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Treatment Type
        • 7.3.3.2.3. By End-User
        • 7.3.3.2.4. By Distribution Channel
    • 7.3.4. Italy Dermocosmetics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Treatment Type
        • 7.3.4.2.3. By End-User
        • 7.3.4.2.4. By Distribution Channel
    • 7.3.5. Spain Dermocosmetics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Treatment Type
        • 7.3.5.2.3. By End-User
        • 7.3.5.2.4. By Distribution Channel

8. Asia Pacific Dermocosmetics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Treatment Type
    • 8.2.3. By End-User
    • 8.2.4. By Distribution Channel
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Dermocosmetics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Treatment Type
        • 8.3.1.2.3. By End-User
        • 8.3.1.2.4. By Distribution Channel
    • 8.3.2. India Dermocosmetics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Treatment Type
        • 8.3.2.2.3. By End-User
        • 8.3.2.2.4. By Distribution Channel
    • 8.3.3. Japan Dermocosmetics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Treatment Type
        • 8.3.3.2.3. By End-User
        • 8.3.3.2.4. By Distribution Channel
    • 8.3.4. South Korea Dermocosmetics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Treatment Type
        • 8.3.4.2.3. By End-User
        • 8.3.4.2.4. By Distribution Channel
    • 8.3.5. Australia Dermocosmetics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Treatment Type
        • 8.3.5.2.3. By End-User
        • 8.3.5.2.4. By Distribution Channel

9. Middle East & Africa Dermocosmetics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Treatment Type
    • 9.2.3. By End-User
    • 9.2.4. By Distribution Channel
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Dermocosmetics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Treatment Type
        • 9.3.1.2.3. By End-User
        • 9.3.1.2.4. By Distribution Channel
    • 9.3.2. UAE Dermocosmetics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Treatment Type
        • 9.3.2.2.3. By End-User
        • 9.3.2.2.4. By Distribution Channel
    • 9.3.3. South Africa Dermocosmetics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Treatment Type
        • 9.3.3.2.3. By End-User
        • 9.3.3.2.4. By Distribution Channel

10. South America Dermocosmetics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Treatment Type
    • 10.2.3. By End-User
    • 10.2.4. By Distribution Channel
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Dermocosmetics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Treatment Type
        • 10.3.1.2.3. By End-User
        • 10.3.1.2.4. By Distribution Channel
    • 10.3.2. Colombia Dermocosmetics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Treatment Type
        • 10.3.2.2.3. By End-User
        • 10.3.2.2.4. By Distribution Channel
    • 10.3.3. Argentina Dermocosmetics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Treatment Type
        • 10.3.3.2.3. By End-User
        • 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Dermocosmetics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. The Procter & Gamble Company
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. L'Oreal S.A
  • 15.3. Unilever PLC
  • 15.4. Johnson & Johnson Services, Inc.
  • 15.5. The Avon Company
  • 15.6. Bausch Health Companies Inc.
  • 15.7. Galderma SA
  • 15.8. Kanebo Cosmetics Inc.
  • 15.9. Beiersdorf AG
  • 15.10. AMOREPACIFIC US, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer